Skip to Content

Raia Drogasil SA RADL3

Morningstar Rating
BRL 25.65 −0.52 (1.99%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RADL3 is trading at a 553% premium.
Price
BRL 25.72
Fair Value
BRL 67.67
Uncertainty
Medium
1-Star Price
BRL 36.29
5-Star Price
BRL 29.44
Economic Moat
Ljgwx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RADL3 is a good fit for your portfolio.

Trading Information

Previous Close Price
BRL 26.17
Day Range
BRL 25.4126.22
52-Week Range
BRL 24.3030.15
Bid/Ask
BRL 0.00 / BRL 0.00
Market Cap
BRL 43.99 Bil
Volume/Avg
5.1 Mil / 7.5 Mil

Key Statistics

Price/Earnings (Normalized)
39.47
Price/Sales
1.26
Dividend Yield (Trailing)
0.75%
Dividend Yield (Forward)
0.75%
Total Yield
0.75%

Company Profile

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Large Growth
Total Number of Employees
57,708

Comparables

Valuation

Metric
RADL3
PGMN3
HYPE3
Price/Earnings (Normalized)
39.4748.5810.92
Price/Book Value
7.390.521.64
Price/Sales
1.260.112.41
Price/Cash Flow
22.744.2310.84
Price/Earnings
RADL3
PGMN3
HYPE3

Financial Strength

Metric
RADL3
PGMN3
HYPE3
Quick Ratio
0.480.371.31
Current Ratio
1.431.391.81
Interest Coverage
2.760.482.42
Quick Ratio
RADL3
PGMN3
HYPE3

Profitability

Metric
RADL3
PGMN3
HYPE3
Return on Assets (Normalized)
5.42%−0.16%7.37%
Return on Equity (Normalized)
18.13%−0.58%15.71%
Return on Invested Capital (Normalized)
13.25%6.02%11.67%
Return on Assets
RADL3
PGMN3
HYPE3
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncPxgknvfxgZwvcl$14.8 Bil
RADLY
Raia Drogasil SA ADRZzbkgl$8.8 Bil
ALBHF
Alibaba Health Information Technology LtdWyqpsw$6.5 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRVdtryz$6.5 Bil
CLCGY
Clicks Group Ltd ADRKztnzf$3.8 Bil
SDGCF
Sundrug Co LtdJbd$3.2 Bil
SGIPF
Sugi Holdings Co LtdNgkw$2.7 Bil
SAEYY
Redcare Pharmacy NV ADRTbrwk$2.5 Bil
SHPPF
Redcare Pharmacy NVMvbdsb$2.4 Bil
ZRSEF
DocMorris AGYprb$1.0 Bil

Sponsor Center